Literature DB >> 1433003

99mTc human immunoglobulin scintigraphy--a reliable method to detect joint activity in rheumatoid arthritis.

M H de Bois1, J W Arndt, E A van der Velde, P A van der Lubbe, M L Westedt, E K Pauwels, F C Breedveld.   

Abstract

The ability of 99mtechnetium labelled nonspecific, polyclonal human immunoglobulin G (99mTc-IgG) scintigraphy to depict and quantify synovial inflammation was studied in 30 patients with rheumatoid arthritis (RA). All patients were injected with 350 MBq 99mTc-IgG and imaging was performed 4 h later. This resulted in excellent images of inflamed synovium. Scores for 99mTc-IgG joint scintigraphy correlated highly with scores for joint swelling and C-reactive protein levels, weakly with pain scores and not with radiographic scores of joint destruction. These results suggest that 99mTc-IgG joint scintigraphy may provide an objective test to detect synovitis and measure the activity of the disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433003

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

Review 1.  Passage of intravenous immunoglobulin and interaction with the CNS.

Authors:  U Wurster; J Haas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

2.  Radionuclide imaging with human polyclonal immunoglobulin (Tc-HIG) and bone scan in patients with rheumatoid arthritis and serum-negative polyarthritis.

Authors:  G Gerasimou; E Moralidis; E Papanastasiou; G Liaros; T Aggelopoulou; E Triantafyllidou; N Lytras; L Settas; A Gotzamani-Psarrakou
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

3.  Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.

Authors:  R J Verburg; R Flierman; J K Sont; F Ponchel; L van Dreunen; E W Levarht; M M Welling; R E M Toes; J D Isaacs; J M van Laar
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

4.  Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset.

Authors:  M H de Bois; M L Westedt; J W Arndt; K S Wiarda; E A van der Velde; E K Pauwels; F C Breedveld
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

5.  Lung scintigraphy with nonspecific human immunoglobulin G ((99m)Tc-HIG) in the evaluation of pulmonary involvement in connective tissue diseases: correlation with pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT).

Authors:  Ch Kostopoulos; J Koutsikos; C Toubanakis; L A Moulopoulos; Ch Mamoulakis; E Gialafos; P P Sfikakis; Ch Zerva; M Mavrikakis; A Leondi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-06       Impact factor: 9.236

6.  Technetium-99m human immunoglobulin imaging in patients with subacromial impingement or adhesive capsulitis.

Authors:  G P Clunie; J Bomanji; P Renton; J C Edwards; P J Ell
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 7.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10

Review 8.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

9.  Role of scintigraphy with ⁹⁹mTc-infliximab in predicting the response of intraarticular infliximab treatment in patients with refractory monoarthritis.

Authors:  F Conti; G Malviya; F Ceccarelli; R Priori; A Iagnocco; G Valesini; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05-16       Impact factor: 9.236

Review 10.  Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies.

Authors:  G Malviya; F Conti; M Chianelli; F Scopinaro; R A Dierckx; A Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-24       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.